0
There are 58 products.
Active filters
Category: Injectable compounds (pen format)
Active substance: Insulin Asparte
Packaging: 3 ml x 100 IU, total 300 IU
Manufacturer: Novo Nordisk
Half-life: approximately 1 to 1.5 hours
Category: Adenosine analogue
Active substance: 5-aminoimidazole-4-carboxamide ribonucleotide
Packaging: 50 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 3 to 5 hours
Abused dose: 10 to 50 mg 1 to 2 times daily
Category: Injectable substances
Active ingredient: Human Menopausal Gonadotropin (HMG), contains LH + FSH
Packaging: 1 ampoule / 75 IU
Manufacturer: Puretrig
Half-life: 20 to 40 hours
Common abuse dosage: 75 IU every second to third day
Category: Oral substances
Active ingredient: Testosterone Undecanoate
Packaging: 30 tablets x 40 mg
Manufacturer: Careclub India
Half-life: 3 to 5 hours
Dosage: 160 to 320 mg daily
Category: Injectable Steroids
Active ingredient: Testosterone Enanthate
Packaging: 10 ml / 2500 mg
Half-life: 4 to 5 days
Abused dose: most commonly 200 to 1000 mg weekly
Category: Oral substances (opioid, medication for acute pain)
Active ingredient: Tapentadol
Packaging: 10 tablets × 100 mg
Half-life: approx. 4 hours
Dosage: 50 to 100 mg every 4 to 6 hours, maximum daily dose 600 mg
Category: synthetic peptide (GHRP)
Active substance: Growth Hormone Releasing Peptide-2 (increase in growth hormone and IGF-1 levels, improved sleep, fat reduction)
Packaging: 10 mg/vial
Half-life: approx. 0.5 to 1 hour
Abused dose: 100 to 300 mcg daily
Category: synthetic peptide (GHRP)
Active substance: Growth Hormone Releasing Peptide-6 (increase in growth hormone and IGF-1 levels, improved sleep, fat reduction)
Packaging: 10 mg/vial
Half-life: approx. 0.5 to 1 hour
Abused dose: 100 to 300 mcg daily
Category: Injectable compounds (GLP-1, GIP, and glucagon receptor agonist; experimental weight loss medication)
Active ingredient: Retatrutide
Packaging: Vial containing 10 mg
Half-life: approximately 5–7 days
Dosage: Most commonly 2.5 to 12 mg weekly (typically titrated gradually based on tolerance)
Category: Injectable compounds (GLP-1 and GIP receptor agonist, medication for weight loss support)
Active ingredient: Tirzepatide
Packaging: Vial containing 10 mg
Half-life: approximately 5 days
Dosage: Most commonly 2.5 to 15 mg weekly (typically starting at 2.5 mg per week with gradual dose escalation based on tolerance)